ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nym Named Among Top 25 Companies in Healthcare Software for 2024 by The Healthcare Technology Report

By: via Business Wire

Nym, the leader in autonomous medical coding, today announced that it has been named among the Top 25 Healthcare Software Companies of 2024 by The Healthcare Technology Report. Among the esteemed companies selected, Nym earned recognition for its multi-specialty solution and the technology’s proven ability to reduce costly administrative burdens associated with medical coding, improve coding accuracy, and speed up payment cycles for health systems and provider groups.

A leader in healthcare sector news, The Healthcare Technology Report delivers insights to over 60,000 executives and aspiring professionals in the industry. For this year’s Top 25 Healthcare Software Companies of 2024 award, the publication selected organizations that are filling gaps in healthcare systems with cutting-edge technologies based on direct feedback from industry professionals, as well as research on each company’s ratings, clients, capital backing, employee growth, and executive reviews, among other factors.

“This award recognizes leaders in the software space who are driving meaningful change via innovation and bolstering the efforts of healthcare organizations across the industry,” said Or Peles, Nym’s CEO. “It’s an honor to be included and recognized for expanding the capabilities of autonomous coding to support new care areas, which is a testament to our remarkable team’s creativity, dedication, and hard work.”

Powered by innovative Clinical Language Understanding (CLU) technology, Nym’s medical coding engine is bringing greater accuracy and efficiency to revenue cycle management for over 250 healthcare facilities across the U.S. The Nym engine deciphers physician notes in patient charts and assigns medical billing codes, currently supporting six specialties and service lines including emergency medicine, radiology, outpatient surgery, outpatient visits, inpatient professional services, and urgent care. With zero human intervention, Nym’s engine codes patient charts in a matter of seconds with over 95 percent accuracy, enabling healthcare providers to optimize resource allocation and reduce coding costs, the risk of denials, and missed revenue.

Additional information about The Healthcare Technology Report’s Top 25 Healthcare Software Companies of 2024, including the full list of winners, can be found here.

About Nym

Nym is the leader in transforming clinical language into actionable information, which can remove inefficiencies that add billions to the cost of care. By combining industry-leading technology with clinical expertise and a deep understanding of medical language, Nym is able to accurately decode medical charts in a way that is fast, explainable, and compliant. The Company’s innovative solution for revenue cycle management (RCM) takes provider notes within patient charts and translates them into accurate diagnostic and billing charge codes, all within a matter of seconds and with zero human intervention. Along with over 95% accuracy, Nym’s RCM solution delivers audit-ready, traceable documentation for every code it generates, ensuring total visibility into why each code was assigned. The Nym solution can be quickly deployed and scaled based on volume and workflow needs, easing administrative burdens and allowing clinical teams to spend more time focused on patient care.

Based in New York City with R&D capabilities in Tel Aviv, Nym is building an interdisciplinary team of specialists including technologists, physicians, mathematicians, computational linguists, engineers, medical coders and more. Investors in Nym include Addition, GV, Bessemer Venture Partners, Dynamic Loop Capital, Tiger Global, Zach Weinberg and Nat Turner. To learn more about Nym, visit nym.health.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.